Status:
COMPLETED
The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)
Lead Sponsor:
Seoul National University Hospital
Conditions:
Anesthesia, General
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to assess the effects of inhalation agent on corrected QT interval duration during liver transplantation.
Eligibility Criteria
Inclusion
- elective liver transplantation
Exclusion
- age \< 18, age \> 65
- patient refusal
- re-transplantation
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01899248
Start Date
December 1 2012
End Date
November 1 2013
Last Update
May 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea